Intimate Rose review
Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.
Intimate Rose — FDA warning letter, September 2025. Addressed to Intimate Rose, and public in FDA’s warning-letter database.
- Semaglutide
- From $169/mo (all doses, compounded)
- Tirzepatide
- From $169/mo (all doses, compounded)
- Coverage
- Not disclosed
- Brand-name
- Yes
The scorecard
Intimate Rose scored on our six published factors. See the methodology.
What we like
- Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
- Medication and free delivery included, HSA and FSA eligible, no contract
- Backed by an established women's-health brand using the OpenLoop provider network
The caveats
- State availability not published
- Oral compounded GLP-1 only; no injectable option shown
- No specific compounding pharmacy named (network fulfillment via OpenLoop)
- FDA issued a warning letter to Intimate Rose in September 2025; it is public in FDA's warning-letter database
The verdict
Best for: Women's-health brand shoppers wanting oral compounded glp-1. Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.
Ranked #68 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between HealthSource at #67, 77/100 above and Medro at #69, 77/100 below, with the RestorLife Med ruling the next one down.
If that ruling leaves you undecided, the 7 programs we rank against Intimate Rose are graded on the same six factors and listed in score order.For the wider picture, every ruling we have published ranks the field on the same six factors. We have also ruled on it directly: CoreAge Rx vs Intimate Rose goes to CoreAge Rx, 94/100 to 77/100.
Compare with other providers
The closest rulings to Intimate Rose by Verdict Score — the realistic shortlist if you are weighing this one up.
- #45FitFlow— FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).79/100
- #46Nalena— Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.79/100
- #47Piper— Telehealth weight loss provider offering competitively priced compounded GLP-1 medications.79/100
- #48Ageless— An unusually deep compounded menu under one roof — GLP-1, NAD+, sermorelin and TRT, injectable and sublingual — but every figure it advertises is a twelve-month prepay, the month-to-month rate is $279 semaglutide and $349 tirzepatide, and FDA issued a warning letter to its named operator in September 2025.76/100
- #49Bodybuilding Health+— The Bodybuilding.com fitness brand's new compounded-telehealth arm publishes both ladders in full, and they run in opposite directions: semaglutide steps down from $179/mo to $139/mo on a 12-month prepay, while every tirzepatide bundle costs MORE per month than its $209 month-to-month rate — $286, $250 and $244 — with each badged as a saving. Wrapped in an unusually deep NAD+/sermorelin/peptide menu, but the verdict lands it near the bottom: a brand-new operator (Dynamo Group LLC, launched April 2026) selling compounded, not-FDA-approved meds on an all-sales-final policy, with the pharmacy and provider network unnamed on-site and no LegitScript listing we could verify.76/100
- #50Breeze Meds— A LegitScript-certified nationwide program that charges nothing until a provider approves you — but hides its pricing until you are inside the intake.76/100
Pricing, states and verification reflect Intimate Rose's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Intimate Rose's site. Not medical advice; see our disclosure.